Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: Although the release doesn’t give actual costs of warfarin versus some of the newer drugs, or factor in the cost of the usual monthly blood testing required of those taking the drug, it does note the cost of the gene testing used for the study, and that the $200 price tag is now less than a month’s prescription of one of the newer anti-coagulants on the market. The release gives results in both actual numbers of patients and the percentage of reduction of adverse events in those given the genetic test and a comparison group. Although it does so in general terms, the release covers the essentials: the risk of using blood thinners like warfarin and the risks of not using them. The release offers a good description of the design of the study. It was randomized and enrolled more than 1,600 older patients at high risk of blood clots following surgeries. The release explains that one group received warfarin dosing based on standard factors (age, height and weight) and the second group was dosed using these clinical factors plus their genetic variants. The release also offers a detailed breakdown on how many fewer side effects occurred among patients had genetic testing completed compared to those who didn’t. No mongering here. Nicely done and quite complete. Although the release briefly mentions the availability of a “newer anticoagulant,” it should have included a sentence or two about these newer injectable drugs and their overall risks and benefits in comparison to warfarin. It would also have been helpful to tell readers whether the genetic testing that appears to play a role in safer warfarin dosing would have clinical relevance for informing the use of the new blood thinners as well. The fact is that genetic testing is irrelevant for the newer anti-coagulants because they operate in a completely different manner. But all the blood thinners — old and new — carry the same risk of bleeding. The problem with warfarin is the variability in blood levels which requires frequent monitoring, hence the genetic tests to guide dosing. The careful reader will get it: testing for these genetic variants is still an experimental practice for the most part, and further testing of how the mutations affect warfarin is needed. But the release could have been more explicit in saying that no one is yet recommending genetic testing for millions of warfarin users. While the genetic tests are “available” in the sense that anyone can order them for the most part, they are not routinely used clinically and probably wouldn’t be covered by insurance so in that sense they are not widely available to most people. The release describes how the genetic test used in the new study differs from previous similar studies. Overall the language is careful and contextual. The headline should have been toned back a bit to note that this is early research and more study is needed before concluding that “Genetic testing helps set safe dose of common blood thinner,” as the headline now states. Claim: Genetic testing helps set safe dose of common blood thinner
[A]: This news release describes results of a study designed to learn whether testing for the presence of three gene variants could make dosing with the blood thinner warfarin safer for patients given the drug to prevent blood clots after joint replacement surgery. The study found a modest reduction in the risk of bleeding or clots (from over- or under-dosing) in those whose regimens were developed in part by genetic testing for the variants, compared to those whose doses were calculated without the genetic testing. The release does an overall good job in describing the study, its purpose and design; and in quantifying the results. It could have been even stronger if it had included more information about newer alternatives to warfarin that are growing in use and an explicit statement that no one is yet recommending routine genetic testing for the variants based on this study. And although the headline somewhat over promises clinical benefit at this point in time, thoughtful readers will come away with a decent understanding of the context of the research and its potential impact. Some estimates put the number of Americans regularly taking the clot-preventing blood thinner warfarin and several newer anticoagulants at more than six million. Warfarin (sold under the brand name Coumadin) requires frequent blood testing to address risks of overdoses (and potentially lethal bleeding) and under-dosing (ineffective prevention of strokes and other blood clots). Because warfarin is cheap, and its effects are reversible with vitamin K, research designed to make it easier and safer for patients to take is likely to be highly newsworthy for them and their caregivers.


[Q]: Paragraph: House Speaker Jose Oliva was unsparing in his criticism of what he called the “healthcare industrial complex,” including drug companies, hospitals and medical device companies that he said were “the great robber-barons of our time.” Oliva sought to build on some of health care initiatives of last year’s legislative session, including passage of a first-in-the-nation drug importation bill. “We did not choose healthcare as our priority,” he said. “No, it chose us. It chose us through the sheer audacity of the defenders of the status quo.” With a presidential election looming this fall, fierce partisan divides could influence the work of lawmakers. But an air of collegiality prevailed Tuesday, as bouquets festooned the chambers and the Capitol halls and rotundas pulsed with activity. Opening day was also important for lobbyists and the activists who seek to influence lawmakers and the legislation that will be crafted over the 60 days the Legislature has to complete its business before adjourning. While DeSantis enjoys strong relationships with lawmakers — particularly his fellow Republicans who run both chambers of the statehouse — he may not necessarily get everything he wants during his second year as the state’s chief executive. His $91.4 billion budget calls for major spending on the environment and education — including a nearly $1 billion outlay for teacher raises and bonuses. Some fiscally conservative lawmakers said they would give the spending intense scrutiny. On the eve of the Legislature’s opening day, thousands of educators and their allies descended on the Capitol to draw attention to the governor’s plan, calling it flawed because of potential pay inequities and because veteran educators and non-teaching school employees would be left out. Some key Republicans have also cast doubt on the governor’s plan to require employers to use a federally operated electronic database known as E-Verify to check the immigration status of workers. E-Verify has been opposed by agriculture, construction, tourism interests and other industries that rely on immigrant labor. Hundreds of bills await, encompassing education spending, health care, the environment and public safety — as well as approving the billions of dollars required to keep the country’s third-most populous state operating day to day. Legislative Democrats are pushing for stronger gun control measures, but face long odds to win over their Republican colleagues. Addressing a joint session of the state House and Senate during his State of the State address, DeSantis urged cooperation — particularly when it comes to approving his agenda on the environment and education. “This is Florida’s season of opportunity,” DeSantis told lawmakers. “We have the chance to build on a strong foundation, the chance to face the challenges before us and the chance to leave a legacy of success that will benefit our people now and in the future.” Rep. Chris Sprowls, a Republican who’s next in line to be House speaker, commended DeSantis for the sweep of his speech -- covering priorities, he said, that were crucial to Florida’s future. “The members of the House want to help the governor because we believe in the same thing,” Sprowls said. However, Sprowls declined to discuss the merits of specific legislation proposed by the governor, saying that task will be undertaken in the days and weeks to come. And while the governor’s agenda appeared “bright,” he said, “nothing is ever a slam dunk.” In his opening remarks, Senate President Bill Galvano, a Republican, reminded lawmakers of their weighty responsibility. “As we go into this session let us continue to show our constituents that we can exchange and debate ideas while maintaining civility and decorum,” he told the chamber. “That we can problem solve together. That we can put aside personalities and politics for good policy. And, that we are not a microcosm of Washington, D.C., but instead will continue to be an example for Washington, D.C.” Claim: Florida Legislature sets sights on education, health care.
[A]: Florida lawmakers signaled that they would likely tackle education spending and health care costs but might seek to avoid a battle over forcing employers to verify the immigration status of workers, as the 2020 legislative session began Tuesday.


[Q]: Paragraph: On July 16, 2020, as the U.S. recorded its single highest number of COVID-19 cases since the coronavirus health crisis began, U.S. President Donald Trump spoke at an event held on the South Lawn of the White House, ostensibly on the subject of “Rolling Back Regulations to Help All Americans.” During his talk, according to a meme, Trump allegedly tackled the subject of energy-efficiency standards which have supposedly resulted in home appliances that do not function properly due to requirements aimed at conserving the amount of water and power they consume:  This was an accurate reproduction of a portion of Trump’s talk, according to a White House transcript of the event: We’re bringing back consumer choice in home appliances so that you can buy washers and dryers, showerheads and faucets. So showerheads — you take a shower, the water doesn’t come out. You want to wash your hands, the water doesn’t come out. So what do you do? You just stand there longer or you take a shower longer? Because my hair — I don’t know about you, but it has to be perfect. Perfect. Dishwashers — you didn’t have any water, so you — the people that do the dishes — you press it, and it goes again, and you do it again and again. So you might as well give them the water because you’ll end up using less water. So we made it so dishwashers now have a lot more water. And in many places — in most places of the country, water is not a problem. They don’t know what to do with it. It’s called “rain.” They don’t have a problem. This was far from the first time the president had riffed on poorly functioning appliances. In December 2019, as Trump spoke in the Roosevelt Room of the White House amidst an impeachment inquiry, he digressed into railing about toilets and other bathroom fixtures that allegedly frustrate their users due to the use of low-flow technology. CNN reported: The President claimed Americans are flushing their toilets “10 times, 15 times, as opposed to once” and argued that they are having difficulty with washing their hands in what appeared to be a tangent about low-flow sinks and toilets. “We have a situation where we’re looking very strongly at sinks and showers and other elements of bathrooms where you turn the faucet on — and in areas where there’s tremendous amounts of water, where the water rushes out to sea because you could never handle it, and you don’t get any water,” the President said during a roundtable with small business leaders about deregulatory actions. “You turn on the faucet and you don’t get any water. They take a shower and water comes dripping out. Just dripping out, very quietly dripping out,” the President continued, lowering his voice as he spoke about the drips. “People are flushing toilets 10 times, 15 times, as opposed to once.” It wasn’t entirely clear what he was talking about, but it appeared to have to do with bathroom fixtures with low-flow appliances. He said the Environmental Protection Agency was looking into the issue on his suggestion. “They end up using more water. So (the) EPA is looking at that very strongly at my suggestion,” Trump said, though he did not give details on what suggestions, if any, he made. NPR quoted the Pacific Institute, a non-profit research institute with a focus on global and regional freshwater issues, as asserting that Trump’s statements did not comport with reality: Peter Gleick with the Pacific Institute in Oakland considers this all to be Trumpian nostalgia for a time when showers were strong, toilets used 4 gallons a flush and lightbulbs burned your hands when you touched them. Gleick said these newer household items are part of an “efficiency revolution,” doing the same tasks with less and halting the upward trajectory of water and energy consumption in America. And, yes, a dishwasher cycle takes longer, and incandescent bulbs are cheaper to buy upfront. But in the long run, “They’re much more expensive, because they use a huge amount of energy, which we pay for over time and they burn out 20 times faster,” Gleick said. Claim: President Trump gave a talk during the COVID-19 pandemic in which he remonstrated about showers and dishwashers not functioning properly due to low-flow standards.
[A]:
Based on the way Trump talks about efficient lightbulbs, it seems his complaint is with compact fluorescent bulbs, which were the only low-energy bulbs widely available 10 years ago. But today, store shelves are full of LED bulbs with warmer-looking light and even longer life spans. Gleick suspects Trump’s toilet complaints are outdated as well, because low-flow toilet technology has come a long way in recent years.